Christopher J. Coughlin, Director at Allergan plc (AGN), bought 10,000 shares at $163.30 ($1.6M) on 2017-12-05, disclosed to the SEC on 2017-12-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CNC | BUY | 2022-05-03 | $976K | — | Filing → |
| AGN | BUY | 2018-09-07 | $3.5M | — | Filing → |
| ALXN | BUY | 2018-05-02 | $1.2M | — | Filing → |